UNICA IRIS Institutional Research Information System

COCCO, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 491.890
NA - Nord America 24.610
AS - Asia 11.582
SA - Sud America 1.868
AF - Africa 299
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 25
Totale 530.303
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 484.609
US - Stati Uniti d'America 24.240
SG - Singapore 4.671
CN - Cina 3.814
BR - Brasile 1.434
UA - Ucraina 1.264
SE - Svezia 1.261
NL - Olanda 1.224
VN - Vietnam 1.101
DE - Germania 894
FI - Finlandia 714
GB - Regno Unito 669
FR - Francia 606
HK - Hong Kong 423
IN - India 260
CA - Canada 214
KR - Corea 185
AR - Argentina 153
BD - Bangladesh 151
TR - Turchia 118
IQ - Iraq 115
JP - Giappone 108
RU - Federazione Russa 101
MX - Messico 98
ZA - Sudafrica 95
AT - Austria 81
ES - Italia 77
PL - Polonia 74
PK - Pakistan 70
ID - Indonesia 65
MA - Marocco 64
EC - Ecuador 62
CO - Colombia 56
UZ - Uzbekistan 56
VE - Venezuela 54
BE - Belgio 53
PH - Filippine 51
IR - Iran 49
SA - Arabia Saudita 49
CL - Cile 37
CZ - Repubblica Ceca 35
MY - Malesia 34
IE - Irlanda 33
IL - Israele 30
AE - Emirati Arabi Uniti 26
EU - Europa 25
LT - Lituania 25
AU - Australia 24
AZ - Azerbaigian 24
JO - Giordania 24
KE - Kenya 24
TN - Tunisia 24
EG - Egitto 23
DZ - Algeria 22
GR - Grecia 19
RO - Romania 19
UY - Uruguay 19
NP - Nepal 18
PY - Paraguay 18
CH - Svizzera 16
PE - Perù 16
BO - Bolivia 15
OM - Oman 15
TH - Thailandia 15
AL - Albania 14
KZ - Kazakistan 14
PS - Palestinian Territory 14
PT - Portogallo 14
TW - Taiwan 14
DK - Danimarca 11
HU - Ungheria 11
CR - Costa Rica 10
DO - Repubblica Dominicana 10
HR - Croazia 10
LB - Libano 10
CI - Costa d'Avorio 9
ET - Etiopia 9
KG - Kirghizistan 9
KW - Kuwait 9
RS - Serbia 9
PA - Panama 8
BG - Bulgaria 7
EE - Estonia 7
MD - Moldavia 7
JM - Giamaica 6
NG - Nigeria 6
SN - Senegal 6
BH - Bahrain 5
GE - Georgia 5
GT - Guatemala 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
CY - Cipro 4
GY - Guiana 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BY - Bielorussia 3
KH - Cambogia 3
LK - Sri Lanka 3
Totale 530.241
Salva come PNG Salva come JPEG
Città #
Cagliari 472.009
Uta 10.670
Ashburn 2.420
Singapore 2.365
Fairfield 2.335
Woodbridge 1.768
San Jose 1.331
Dallas 1.220
Chandler 1.196
Houston 1.115
Amsterdam 1.102
Boardman 1.051
Wilmington 982
Seattle 940
Ann Arbor 829
Cambridge 778
Nyköping 710
Beijing 697
Jacksonville 588
Los Angeles 560
Helsinki 466
Hong Kong 382
Dearborn 365
New York 354
Chicago 340
Lauterbourg 331
The Dalles 321
Ho Chi Minh City 313
Santa Clara 295
Munich 291
Nanjing 287
Shanghai 276
Boston 258
Hefei 257
Hanoi 235
Buffalo 223
Council Bluffs 192
Milan 179
Seoul 174
Salt Lake City 144
Rome 141
San Diego 136
Guangzhou 131
São Paulo 124
Dong Ket 122
London 111
Shenyang 100
Nanchang 96
Norwalk 96
Toronto 95
Orem 93
Redwood City 90
Atlanta 84
Redondo Beach 83
Tokyo 82
Elk Grove Village 80
Jiaxing 80
Frankfurt am Main 76
Hebei 71
Sassari 71
Tampa 67
Washington 66
Changsha 62
Tianjin 61
Phoenix 59
Warsaw 57
Brooklyn 56
Da Nang 54
Johannesburg 53
Nuremberg 53
Montreal 51
Tashkent 49
Verona 48
Baghdad 45
Stockholm 45
Rio de Janeiro 43
Vienna 43
Jinan 42
Denver 40
Shenzhen 40
Chennai 39
Columbus 39
Hangzhou 39
Sterling 39
Istanbul 38
Turku 37
Brussels 36
Mexico City 36
Mountain View 36
Zhengzhou 36
Düsseldorf 34
Haiphong 33
Dublin 32
Curitiba 30
Manchester 30
Naples 30
Wuhan 30
Lancaster 29
Miami 29
San Francisco 29
Totale 514.026
Salva come PNG Salva come JPEG
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.157
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.967
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.238
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.937
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.578
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.495
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.485
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.390
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.299
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.216
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.211
Overexpression of the cytokine BAFF and autoimmunity risk 4.105
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.036
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.011
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.924
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.902
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.880
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.837
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.836
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.817
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.802
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.731
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.705
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.661
Walking improvements with nabiximols in patients with multiple sclerosis 3.648
Texting while walking differently alters gait patterns in people with multiple sclerosis and healthy individuals 3.618
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.616
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.608
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.586
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.584
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.506
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.433
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.405
Impact of the media on future hope in multiple sclerosis 3.383
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.313
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.305
Multiple Sclerosis and environmental factors. 3.292
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.288
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors? 3.284
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.237
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.211
Oral agents in multiple sclerosis 3.209
Influence of treatments in multiple sclerosis disability: a cohort study 3.179
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.163
Top-down proteomic profiling of human saliva in multiple sclerosis patients 3.137
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.110
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.102
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity 3.069
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study 3.064
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.055
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.041
Smoothness of gait, but not spatio-temporal parameters, are altered in early stages of Multiple Sclerosis 2.991
Refining the connection between gait and cognition: training the body to improve the brain 2.981
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.978
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.975
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.972
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.957
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.950
Validation of the Arm Profile Score in assessing upper limb functional impairments in people with multiple sclerosis 2.922
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.874
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.871
Hourly trends of physical activity in people with Multiple Sclerosis 2.849
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.809
Do gait patterns differ in men and women with multiple sclerosis? 2.801
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.724
Postural adaptation during a Nintendo Wii balance training 2.668
Perception of risk and shared decision making process in multiple sclerosis 2.652
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: A monocentre assessment 2.638
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.636
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1 H-NMR Spectroscopy 2.621
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.615
The relationships between physical activity, self-efficacy, and quality of life in people with multiple sclerosis 2.598
Are static and dynamic balance abilities correlated in people with Multiple Sclerosis? 2.593
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.568
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.556
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.533
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.482
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.443
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.403
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.331
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.327
The cohort of the multiple sclerosis center of Cagliari 2.322
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.312
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.300
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.286
Induction and escalation therapies in multiple sclerosis 2.279
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.273
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.256
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 2.242
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.226
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.206
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.202
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.103
Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study 2.096
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.068
Tardbp ala382thr mutation in multiple sclerosis: A possible role in brain atrophy 2.061
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 2.052
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 2.051
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 2.034
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.022
Totale 315.375
Salva come PNG Salva come JPEG
Categoria #
all - tutte 669.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 669.079
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.299 0 0 0 0 0 0 0 0 0 0 7.062 4.237
2021/202225.919 3.270 1.763 1.115 2.039 2.209 1.580 1.217 1.264 2.468 2.858 3.383 2.753
2022/202336.235 3.108 5.156 5.038 3.231 3.069 3.597 1.763 2.760 2.009 2.109 2.761 1.634
2023/202438.874 2.396 1.901 1.510 2.537 3.741 6.434 5.206 3.347 1.961 2.893 3.507 3.441
2024/202598.907 28.032 28.966 11.450 8.286 4.316 4.788 6.787 483 1.114 1.990 1.689 1.006
2025/202623.293 1.758 1.093 2.417 2.373 1.798 1.840 5.513 2.191 1.870 2.380 60 0
Totale 531.649